-
Cerium Oxide Nanoparticles in the Treatment of Parkinson’s Disease – Toxicity and Biodistribution Studies
… effects. Further, since nanoparticles may persist in the system after initial delivery, we will also examine …
-
Inhibition of Retinoic Acid Metabolism for the Treatment of Parkinson’s Disease
… concentration in cells. We have designed a drug delivery system to administer our compounds in vivo in order to …
-
Toxic Species of Parkinson's Protein Named Focus of Funding Program
April 23, 2014
… human Parkinson’s disease samples: from the central nervous system, including cerebrospinal fluid and brain tissues …
-
Michael J. Fox Foundation-Funded Team Pursuing Glutamate-Based Treatment for Parkinson's Disease Hits Major Milestone
September 30, 2009
… has identified two drug-like molecules that, when given systematically in a pre-clinical model of Parkinson’s … have found two compounds that act on mGluR4 and, when given systemically in a pre-clinical model of Parkinson’s disease, …
-
Ken Griffin Alpha-synuclein Imaging Competition Webinar
October 10, 2019
… by adding a password. Your information is already in our system. Login here to register. Register Thank you for your …
-
ASAP Collaborative Research Network Informational Webinar
November 14, 2019
… by adding a password. Your information is already in our system. Login here to register. Register Thank you for your …